You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

HIQA says over 65s atrial fibrillation screening programme “cost-effective”

By Dermot - 06th Aug 2015 | 6 views

Atrial fibrillation is the most common abnormal heart rhythm seen in general practice and is associated with a five times increase in the risk of stroke.

Today HIQA published its economic evaluation of a national screening programme for atrial fibrillation and the authority estimates that the total incremental cost to the HSE is approximately €3.7 million over the first five years.

“Based on the best available evidence, annual opportunistic pulse palpation for those aged 65 and older is expected to lead to reductions in the incidence and severity of atrial fibrillation-related strokes,” said Dr Máirín Ryan HIQA’s Director of Health Technology Assessment.

“This is assuming that those detected by screening have a comparable risk of stroke as those detected through routine care.”

Atrial fibrillation screening aims to detect the risk of stroke in an individual as early as possible.

“Our analysis estimates that screening would result in the detection of one additional atrial fibrillation case for every 22 people screened from age 65 onwards, and one stroke avoided for every 270 people screened over the same period,” said Dr Ryan.

“The total incremental cost to the HSE is approximately €3.7 million over the first five years. This includes the additional costs associated with screening ECGs and atrial fibrillation drug therapy in diagnosed cases, as well as the cost savings resulting from a gradual decrease in stroke incidence over a period of five years.”








Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]